MedTrace Logo

Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial

NCT03010137 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-06-09

Study results available
· View outcomes & findings →

Summary

Incisional negative pressure therapy (INPWT) has previously been shown in certain patient populations to decrease wound healing complications, decrease the rate of hematomas and seromas, as well as have better scar quality. We have found a group of patients, those who have panniculectomies in preparation for renal transplant, with significantly higher rates of wound healing complications. We believe the best way to demonstrate benefits of incisional negative pressure wound therapy will be in this group of patients known to have significantly higher rates of wound complications.

Conditions

  • Complications Wounds
  • Negative Pressure Wound Therapy
  • Wound Healing Delayed
  • Incisional
  • Panniculectomy
  • Incisional Negative Pressure Wound Therapy
  • Incisional Vac
  • Wound Vac
  • Obese
  • Renal Failure
  • Kidney Transplant; Complications
  • Wound Healing Complication

Interventions

PROCEDURE

Incisional Negative Pressure Wound Therapy

PROCEDURE

Standard Closure with Skin Glue

DEVICE

PICO (Smith&Nephew)

Off the shelf, disposable negative pressure wound therapy device. Contains sterile dressing as well as an attached small (pager sized) suction device/canister.

DEVICE

Dermabond

Final wound closure with skin glue.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Michael S Wong, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2019-03-13
Completion
2019-03-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010137 on ClinicalTrials.gov